Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Medicinal Chemistry|July 14, 2023
Phototoxicity─Medicinal Chemistry Strategies for Risk Mitigation in Drug DiscoveryTyler J Harrison, Xin Chen, Kayo Yasoshima, et al.Chemical & Pharmaceutical Bulletin|October 6, 2005
Benzimidazole-5-sulfonamides as novel nonpeptide luteinizing hormone releasing hormone (LHRH) antagonists: minimization of mechanism-based CYP3A4 inhibitionKentaro Hashimoto, Mikayo Kataoka, Miyuki Tatsuta, et al.Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamidesYingfu Li, Mikayo Kataoka, Miyuki Tatsuta, et al.International Journal of Toxicology|June 9, 2017
Correlation Between Nasal Epithelial Injury and In Vitro Cytotoxicity Using a Series of Small Molecule Protein Tyrosine Phosphatase 1B Inhibitors Investigated for Reversal of Leptin Resistance in ObesityAlan P Brown, Chandrassegar Saravanan, Patrick Devine, et al.Bioorganic & Medicinal Chemistry Letters|April 20, 2005
Benzimidazoles as non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 3: Discovery of 1-(1H-benzimidazol-5-yl)-3-tert-butylurea derivativesMiyuki Tatsuta, Mikayo Kataoka, Kayo Yasoshima, et al.Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 1: Benzimidazole-5-sulfonamidesKentaro Hashimoto, Miyuki Tatsuta, Mikayo Kataoka, et al.Bioorganic & Medicinal Chemistry Letters|April 25, 2012
Tetrahydro-naphthols as orally available TRPV1 inhibitorsKlaus Urbahns, Takeshi Yura, Jang B Gupta, et al.Journal of Medicinal Chemistry|October 17, 2017
Discovery of a Novel Piperidine-Based Inhibitor of Cholesteryl Ester Transfer Protein (CETP) That Retains Activity in Hypertriglyceridemic PlasmaKen Yamada, Margaret Brousseau, Wataru Honma, et al.Journal of Medicinal Chemistry|August 4, 2017
Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension ModelsKen Yamada, Julian Levell, Taeyong Yoon, et al.ACS Chemical Biology|October 8, 2016
Discovery and Characterization of Allosteric WNK Kinase InhibitorsKen Yamada, Ji-Hu Zhang, Xiaoling Xie, et al.Pageof 2